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Influence of LRP5 (rs556442) polymorphism on insulin resistance in healthy Iranian
children and adolescents
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Background/aim: Genetic aspects play a role in insulin resistance in children. In this study, for the first time, the association of LRP5
(rs556442) polymorphism and insulin resistance in Iranian children and adolescents was investigated.
Materials and methods: The study population comprises children and adolescents aged 9–18 years. Anthropometric and biochemical
parameters were assessed. Insulin resistance/sensitivity was determined by the quantitative insulin sensitivity check index (QUICKI),
homeostasis model assessment-insulin resistance (HOMA-IR), insulin-to-glucose ratio, McAuley index, revised McAuley index, fasting
insulin resistance index (FIRI), and Bennett’s index. LRP5 (rs566442) single nucleotide polymorphism (SNP) was identified using
restriction fragment length polymorphism (RFLP). Linear regression analysis was used to determine the association between the LRP5
polymorphism (rs556442) and insulin sensitivity indexes.
Results: Significant differences were found between GG genotype vs. AG/AA genotypes for McAuley index (P = 0.049) and revised
McAuley index (P = 0.044) when adjusted for interaction factors (age, sex, and puberty) in regression models. No significant association
was found between LRP5 (rs566442) and other insulin resistance indexes. Also, LRP5 (rs566442) did not show a significant impact on
biochemical parameters.
Conclusion: This study showed that LRP5 polymorphism (rs556442) was associated with insulin resistance in Iranian children and
adolescents.
Key words: LRP5, insulin, restriction fragment length polymorphism, revised McAuley index, children

1. Introduction
Insulin resistance (IR) is mostly related to metabolic
disorders such as obesity, metabolic syndrome (MS),
hypertension, type 2 diabetes, chronic hepatitis C, and
ischemic cardiovascular disease (1–7). IR is defined as
defective insulin action in decreasing blood glucose,
according to failing physiological response to insulin
(6,8). In the pediatric and adolescent age group, insulin
resistance is known as a serious health problem associated
with obesity, dyslipidemia, cardiometabolic risk, and
inflammation (1,2). Identifying children with insulin
resistance is a good strategy for preventing high-risk
children from MS interventions (9).
Various methods have been validated for direct
and indirect assessment of insulin resistance in clinical
and epidemiological studies (10). Hyperinsulinemic–
euglycemic clamp as a direct method is a gold standard for
this purpose, but it is expensive and invasive (1,6). Indirect

methods derived from fasting insulin and glucose include
intravenous glucose tolerance test, oral glucose tolerance
test, meal tolerance test, homeostatic model assessment
of insulin resistance (HOMA-IR), quantitative insulin
sensitivity check index (QUICKI), insulin-to-glucose ratio,
fasting insulin resistance index (FIRI), and Bennett’s index
(1,2). Two other indexes based on insulin and triglyceride
(TG), the McAuley index (11) and body mass index (BMI),
and index based on triglyceride, the revised McAuley
index, were also used to determine insulin resistance in
research/epidemiological studies (10). HOMA-IR is a
marker of insulin resistance and beta cell function that is
a noninvasive method used to compare insulin secretion
and insulin resistance (12,13). The McAuley index, as
reported in various studies, is a precise process with better
reproducibility to measure IR than other indexes (14).
Genetic aspects play a role in insulin resistance in
both adults and children by creating alterations in the
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pathways related to insulin metabolism (15). The Wnt
signaling pathway is one of the systems that interacts
and modulates the insulin-signaling network (16). Lowdensity lipoprotein (LDL) and receptor-related protein
(LRP5) as a cell membrane receptor have a critical role in
the Wnt signaling pathway (17). Recent studies suggested
that there was a crosstalk between the insulin and Wnt
signaling pathways. This relationship occurs at different
levels and in different cellular contexts (16). In addition,
both insulin and insulin-like growth factor-1 (IGF-1)
stimulation activate the Wnt signaling pathway in the
hepatoma cells (16). Another study showed that LRP5 was
required for normal insulin signaling in preadipocytes
(16). This pathway is involved in various cellular activities
like embryonic development, oncogenesis, myogenesis,
adipogenesis, and glucose homeostasis (17,18). The
Wnt pathway regulates prenatal β-cell development
and postnatal β-cell functions, and its receptor, LRP5,
is highly expressed on adult pancreatic β-cells (19). It
is essential for glucose-induced insulin secretion (17).
LRP5-deficient mice showed impaired glucose tolerance
as a result of impaired insulin production from β-cells in
the pancreas (20). Polymorphisms and mutations in Wnt
and its components such as LRP5 and LRP6 may lead to
increased risks of obesity, osteoporosis, and metabolic
syndrome (16). However, the relationship of LRP5
(rs556442) polymorphism with insulin sensitivity and
insulin resistance in children has not been examined as
yet. For this reason, in this paper we investigated whether
LRP5 (rs556442) polymorphism is associated with insulin
resistance in Iranian children and adolescents.
2. Materials and methods
2.1. Study population
In this cross-sectional study, which was performed in
Kawar, an urban area located 50 km east of Shiraz, the
capital city of Fars Province in the south of Iran, healthy
Iranian children and adolescents aged 9–18 years were
enrolled. Five hundred children and adolescents (250
girls and 250 boys) were selected using age-stratified
systematic random sampling. Among them, 266 children
and adolescents were randomly selected for the genetic
study. The children known to have systemic disease
(e.g., thyroid problems, diabetes, renal failure, adrenal
insufficiency), history of precocious or delayed puberty,
or using medications (e.g., anticonvulsants or steroids)
were not included in the study. Our study was approved
by the ethics committee of Shiraz University of Medical
Sciences. An informed consent form was obtained from
each participant or their parents.
2.2. Anthropometry
Height and weight of the children were measured using a
wall-mounted meter and standard scale (Seca, Germany),

respectively. Height was rounded to the nearest 0.5 cm
and weight to the nearest 0.1 kg. BMI was calculated
by this formula: BMI (kg/m2) = weight (kg) / [height
(m)] 2. Children’s pubertal stages were assessed by an
endocrinologist and bone density was measured by dualenergy X-ray absorptiometry (DEXA). Pubertal stage was
evaluated according to the Tanner standard classification
during the visit for the DEXA scan. Children with Tanner
stages of 1 were considered as prepubertal, 2 and 3 as early
pubertal, and 4 and 5 as pubertal.
2.3. Laboratory tests
All the blood samples were taken in the Shiraz
Endocrinology Research Center after overnight fasting.
Serum total cholesterol, high-density lipoprotein (HDL-C),
fasting blood sugar (FBS), and TG concentrations
were measured by enzymatic reagents (Biosystems,
Barcelona, Spain) with an A-25 Biosystems autoanalyzer.
The serum insulin concentration was measured with a
radioimmunoassay kit (IZOTOP, Budapest, Hungry). In
addition, insulin resistance/sensitivity was determined
by the QUICKI, HOMA-IR, insulin-to-glucose ratio,
McAuley, revised McAuley, FIRI, and Bennett’s indexes
and calculated using the following formulas (21):
QUICKI: 1 / log (glucose mg/dL) + log (insulin µU/
mL)
HOMA-IR: (fasting insulin [microunits per milliliter]
× fasting glucose [millimoles per liter]) / 22.5
Insulin-to-glucose ratio: Insulin (µU/mL) / glucose
(mmol/L)
McAuley: exp [2.63 – 0.28ln (insulin) − 0.31ln
(triglyceride)]
Revised McAuley: exp [3.29 – 0.25ln (insulin) – 0.22ln
(BMI) – 0.28ln (triglyceride)]
FIRI: Insulin (µU/mL) × glucose (mmol/L) /25
Bennett’s index: 1 / log [glucose (mmol/L)] × log
[insulin (µU/mL)]
2.4. Genotyping
LRP5 (rs566442) single nucleotide polymorphism (SNP)
was identified using PCR/RFLP. The details of primer
sequences and PCR conditions were mentioned in our
previous study (22). This SNP (A→G) was located 123 bp
downstream of the starting site in exon 15 of the LRP5
gene. The genomic DNA was extracted from the peripheral
blood with the DNA QIAamp blood kit (QIAGEN, Hilden,
Germany), according to the manufacturer’s instructions.
2.5. Statistical analysis
Data for all variables are shown as means and standard
deviations (SDs) or medians and interquartile ranges. For
data with a normal distribution, t-test and ANOVA, and
for data with nonnormal distribution Mann–Whitney and
Kruskal–Wallis tests were used to evaluate the differences
between the genotype groups. The chi-square (χ2) test or
Fisher’s exact test was used to determine the genotype
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higher than 10%, representing a good penetration of
the alleles in the population. LRP5 (rs566442) genotype
distribution was 41.2% for GG, 45.4% for AG, and 13.4%
for AA in the whole population. There were no differences
between the girls and boys (P = 0.47). The total allelic
frequencies were 0.59 for G and 0.41 for A. In boys, allele
frequency was 34.7% and 65.3% for A and G, respectively.
In girls, it was 37.6% for A and 62.4% for G. There were
no significant differences between allele distribution and
sexes (P = 0.35). The genotype distribution regarding sex
is illustrated in Table 2.
3.3. Effects of rs566442 polymorphism on insulin indexes
The effect of rs566442 polymorphism on insulin function
is shown in Table 2. No significant association was
found among LRP5 genotype and fasting blood glucose,
serum insulin concentration, QUICKI, Bennett’s index,
HOMA-IR, FIRI, insulin-to-glucose ratio, and McAuley
and revised McAuley indexes. However, children with
the AA genotype showed lower values of serum insulin
concentration, QUICKI, Bennett’s, HOMA-IR, FIRI, and
insulin-to-glucose ratio.
3.4. Association of rs566442 polymorphism with McAuley and revised McAuley indexes
Linear regression analysis showed a significant association
between revised McAuley index in the dominant (model
1: P < 0.0001, model 2: P < 0.001) and recessive genetic
models (model 1: P = 0.03, model 2: P = 0.03). No
significant association was observed in McAuley index or

distribution and allele frequencies. Nonnormal data were
log-transformed before analysis. Linear regression analysis
was performed in 2 models to find the association between
insulin resistance/sensitivity indexes and genotype groups
(dominant and recessive) when adjusted for interacting
factors (age, sex, and puberty). For the dominant genetic
model, the GG genotype was set as the reference and
compared to AA+AG genotypes. For the recessive genetic
model, the AG+GG genotype was set as the reference and
compared to the AA genotype. Model 1 was adjusted for
age and sex, and model 2 for age, sex, and puberty. P values
less than 0.05 were considered statistically significant.
All statistical analyses were performed using IBM SPSS
Statistics 22.0 for Windows (IBM Corp., Armonk, NY,
USA).
3. Results
3.1. Clinical and biochemical characteristics
A total of 266 children (139 girls, 127 boys) aged 9–18
years (mean: 13.64 ± 2.86) were enrolled in the study.
The means and SDs for age, weight, height, BMI, fasting
blood sugar, serum insulin concentration, triglycerides,
total cholesterol, LDL-C, HDL-C, HOMA-IR, QUICKI,
Bennett’s, McAuley and revised McAuley, FIRI, and
insulin-to-glucose ratio are shown in Table 1.
3.2. Genotyping
The studied SNPs were in Hardy–Weinberg equilibrium
(P = 0.71) and showed a minor allele frequency (MAF)

Table 1. General characteristics of the study population.
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Variable

Mean ± SD

Median (interquartile range)

Age

13.6 ±

14 (4)

Height

152.5 ± 14.75

154 (20)

Weight

41.65 ± 13.64

42 (20)

BMI

17.51 ± 3.34

17.2 (4.3)

Cholesterol

156.05 ± 30.44

153 (39)

HDL

47.3 ± 15.28

45.5 (15.9)

TG

70.6 ± 45.65

62 (57)

LDL

94.6 ± 27.12

93.3 (34.8)

Fasting blood sugar

78.3 ± 12.41

77 (16)

Insulin

8.9 ± 5.33

7.7 (3.6)

QUICKI

1.4 ± 0.24

1.4 (0.20)

HOMA-IR

1.7 ± 1.24

1.4 (0.83)

Insulin-to-glucose ratio

2.1 ± 1.12

1.7 (0.98)

McAuley

2.3 ± 0.73

2.1 (0.87)

Revised McAuley

2.6 ± 0.61

2.5 (0.70)

FIRI

1.5 ± 1.12

1.3 (0.75)

Bennett’s index

1.4 ± 0.39

1.3 (0.40)

2.86
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Table 2. Genotype counts and frequencies of the rs566442
polymorphism.
Boys

Girls

P-value

GG

58 (42.3%)

50 (40%)

AG

63 (46%)

56 (45%)

AA

16 (11.7%)

19 (15.2%)

Genotypes
0.47

Alleles
G

179 (65.3%)

156 (62.4%)

A

95 (34.7%)

94 (37.6%)

0.35

rs566442 polymorphism in the dominant and recessive
genetic models (Tables 3, 4).
4. Discussion
Insulin resistance is linked to the pathophysiologic
pathways that originate during childhood. Conversely, an
individual’s genetic background variation may possibly
cause alterations in these pathways, which leads to disease
progression (23). In addition to genetic factors, metabolic
factors such as obesity and abdominal fat deposition
impact insulin resistance (13). Several studies on twins
showed 50% change in insulin sensitivity and secretion
in relation to genetic factors (1). Another study suggested
that healthy children with a family history of type 2
diabetes in comparison to those without it were possibly
insulin-resistant (1).
In children and adolescents, IR is not numerically
defined and one biochemical parameter that can explain
IR fully and accurately does not exist. The IR threshold
for prediction of IR is not known. No acceptable cut-off

value with high accuracy is available. Normative data for
distribution of different biochemical markers in childhood
do not exist (24).
In this study, we evaluated the association of LRP5
(rs566442) polymorphism with insulin resistance indexes
HOMA-IR, QUICKI, insulin-to-glucose ratio, McAuley,
revised McAuley, FIRI, and Bennett’s index. To the best
of our knowledge, this is the first study to investigate
the association of LRP5 and insulin resistance in healthy
children with different defined criteria.
In this study, we found a significant association of LRP5
(rs566442) polymorphism with revised McAuley index.
According to the regression analysis, there was a significant
difference in the revised McAuley index between GG and
AG/AA genotypes (dominant model), and AA and AG/
GG genotypes (recessive model). However, we did not
find this association between this genetic variation and
other insulin resistance indexes. As reported previously,
the McAuley and revised McAuley are IR measurement
indexes, which better estimate IR among normoglycemic
individuals (25). In that study, correlation coefficients
of the 5 indices showed that the McAuley index had the
strongest correlation with IR (25). Ascaso et al. observed
that the McAuley index was more specific and sensitive in
the assessment of IR compared to QUICKI (26). Another
study on the nondiabetic offsprings of diabetic individuals
found the highest AUC for metabolic syndrome detection
by using the McAuley index (27).
Carg et al. observed that the McAuley index had the
highest specificity in detecting metabolic syndrome in
urban Indian adolescents (14). In the McAuley and revised
McAuley index, insulin resistance is determined by
measures based on fasting insulin and triglyceride levels.
In this study, we observed that individuals with the GG
genotype had significantly higher revised McAuley index

Table 3. Effect of the LRP5 (rs566442) polymorphism on insulin function indices.
Data

GG (n = 109)

Genotype
AG (n = 119)

Fasting blood sugar

77.83 (12.36)

AA (n = 36)

P-value

78.55 (13.11)

79.33 (10.19)

0.73

Mean (SD)
Insulin

8.96 (5.05)

9.20 (6.01)

8.14 (3.61)

0.79

QUICKI

1.42 (0.23)

1.42 (0.23)

1.37 (0.28)

0.75

HOMA-IR

1.76 (1.19)

1.84 (1.41)

1.60 (0.75)

0.79

Insulin-to-glucose ratio

2.08 (1.06)

2.09 (1.24)

1.86 (0.88)

0.60

McAuley

2.48 (0.86)

2.24 (0.60)

2.20 (0.70)

0.08

Revised McAuley

2.82 (0.76)

2.58 (0.47)

2.45 (0.44)

0.07

FIRI

1.58 (1.07)

1.65 (1.27)

1.44 (0.67)

0.79

Bennett’s index

1.43 (0.38)

1.41 (0.38)

1.33 (0.46)

0.53
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Table 4. Linear regression analysis for association of McAuley and revised McAuley indexes in genotype groups in 2 models.
P values less than 0.05 are shown in bold.
McAuley index
Data

Model 1

Model 2

OR (CI 95%)

P-value

OR (CI 95%)

P-value

Dominant (AA + AG) vs. GG

–0.25 (–0.55 to 0.49)

0.9

–0.22 (–0.53 to 0.1)

0.17

Recessive AA vs. (AG + GG)

–0.25 (–0.55 to 0.56)

0.1

0.02 (–0.45 to 0.5)

0.9

OR (CI 95%)

P-value

OR (CI 95%)

P-value

Dominant (AA + AG) vs GG

–0.27 (-0.42 to 0.12)

<0.0001

–0.26 (–0.4 to –0.1)

<0.001

Recessive AA vs (AG + GG)

–0.23 (–0.4 to 0.1)

0.03

–0.24 (–0.4 to 0.1)

0.03

LRP5 (rs556442)

Revised McAuley index
Model 1

Model 2

LRP5 (rs556442)

Model 1: Adjusted for age and sex. Model 2: Adjusted for age, sex and puberty.

scores compared to AA/AG genotypes. The McAuley and
revised McAuley are IR measurement indexes that better
reflect the lipid profile (28). They were inversely correlated
with TG levels. Many previous studies have confirmed that
IR and the accompanying hyperinsulinemia can directly
affect the lipoprotein metabolism (29). Increased TG
levels, as a result of hyperinsulinemia, also directly cause
pancreatic beta-cell dysfunction due to the accumulation
of TG inside the cells (25). Based on these data, IR indexes
such as the McAuley and revised McAuley could be a good
reflection of dyslipidemia, which occurs due to metabolic
dysfunction and hyperinsulinemia (25).
A few studies have investigated the role of the Wnt
signaling pathway and LRP5 in glucose and insulin
secretion. Fujino et al. observed that glucose-induced
insulin secretion was conducted by LRP5 in mice (17). They
also concluded that LRP5 controls the normal function of
the β-cells through the transcriptional regulation of Tcf1,
Tcf2, and HNF-4α genes (17). Palsgaard et al. found that
the Wnt signaling pathway in 3T3-L1 preadipocytes causes
phosphorylation of Akt, ERK1/2, and GSK3 proteins
involved in insulin signal transduction (16). Decrease in
LRP5 expression also has a negative effect on adipocyte
differentiation and triglyceride accumulation because of
the inhibition of the adipogenesis process by Wnt signaling
(16). Several interesting traits were found about the role
of LRP5 in insulin signaling. First, LRP5 markedly affects
the basal phosphorylation of insulin signaling proteins
and the insulin response in preadipocytes. Second, this
is a mechanism that is especially related to insulin as
compared with IGF-1 in 3T3-L1 cells. Third, LRP5 has
positive effects on insulin signaling via interaction between
LRP5 and insulin receptor (16). These findings show
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that LRP5 plays an important role in insulin signaling
through interaction with insulin receptor induced by
phosphorylation of insulin signaling proteins (16). It
was observed that mutations in LRP5 were significantly
associated with diabetes or impaired glucose tolerance in
a family-based study and this phenotype occurred as the
result of reduction in LRP5 expression, which may lead
to insulin resistance in preadipocytes, varying the balance
of the pro- and antiadipogenic signals and changing
glucose metabolism (30). In another study, individuals
with homozygous or heterozygous LRP5 mutations
(R570W) revealed impaired glucose metabolism with
high frequency, but there was no evidence of insulin
resistance in the subjects (31). However, LRP5 (R1036Q)
mutation displayed obvious impaired beta-cell function
by intravenous glucose tolerance test (31). Kim et al.
found that dysregulation of TG may be the main factor
of early stage IR. Elevation of glucose concentration in
the hepatocytes beyond its capacity to convert glucose to
glycogen results in an increase in the insulin secretion.
Insulin converts the excess glucose to free fatty acids,
and finally these molecules are accumulated as TG. Thus,
TG accumulation represents hyperinsulinemia (25). In
the current study, we found that individuals carrying the
mutant allele compared to those who did not carry this
allele had significantly higher insulin resistance.
Our study had some limitations. Due to the relatively
small sample size, statistical power to detect associations
of LRP5 variants with insulin resistance was limited.
Subjects enrolled in the present study were selected from a
cohort study from the south of Iran and may not represent
the general population of Iranian children. More studies
need to be carried out in Iranian and other population

MONTAZERI-NAJAFABADY et al. / Turk J Med Sci
groups to understand the correlation between LRP5
polymorphism and insulin resistance to further verify our
results. Furthermore, the larger sample size would help to
elucidate the association of LRP5 with insulin resistance
and other metabolic diseases.
In conclusion, this study showed that LRP5
polymorphism (rs556442) was associated with insulin
resistance in Iranian children. However, further studies

should be conducted to evaluate the role of the other
polymorphisms.
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